| EURONEXT |
| Date/Time | / |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | - |
| Previous Close | - |
| High | - |
| Low | - |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | |
| ISIN | NL0006294274 |
| Security | ENX |
| Exchange | Euronext - Paris |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 89.05 |  |
|
| Euronext - P.. | 89.30 |  |
104,112 |
| Cboe Europe .. | 89.60 | |
40,736 |
| London Inter.. | 89.60 | |
23,446 |
| Turquoise | 89.65 | |
22,594 |
| TradeGate | 89.55 | |
161 |
| gettex | 89.400 | |
11 |
| Düsseldorf | 88.95 | |
0 |
| Frankfurt | 87.9500 | |
0 |
| München | 88.30 | |
0 |
| Berlin | 89.35 | |
0 |
| Stuttgart | 89.350 | |
0 |
| Vienna Globa.. | 89.65 | |
0 |
| Cboe Europe .. | 88.25 | 3,063 | |
| Cboe Europe .. | 88.25 | 1,225 | |
| Nasdaq Other.. | 103.0000 | 100 | |
| Euronext - L.. | 38.820 |
News
- Valneva Files Registration Statement for Proposed United States Initial Public Offering
04/10/2021 / 08:00 - GlobeNewswire - Kiadis employee options committed under the Sanofi Offer
04/09/2021 / 07:00 - GlobeNewswire - Oxurion NV – Publication in Progress in Retinal Eye Research highlights the potential of pan-RGD integrin antagonists to improve the treatment of diabetic retinopathy and wet AMD
04/07/2021 / 17:45 - GlobeNewswire - Oxurion NV enters into a Capital Commitment of up to €30 Million with Negma Group
04/06/2021 / 07:30 - GlobeNewswire - OXURION to Participate in Upcoming Investor Meetings
03/31/2021 / 07:30 - GlobeNewswire
Real-time